Advanced Biomedical Technologies Inc
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for… Read more
Advanced Biomedical Technologies Inc (ABMT) - Total Liabilities
Latest total liabilities as of July 2022: $8.70 Million USD
Based on the latest financial reports, Advanced Biomedical Technologies Inc (ABMT) has total liabilities worth $8.70 Million USD as of July 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Advanced Biomedical Technologies Inc - Total Liabilities Trend (2006–2022)
This chart illustrates how Advanced Biomedical Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Advanced Biomedical Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Advanced Biomedical Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kairous Acquisition Corp. Limited Warrants
NASDAQ:KACLW
|
USA | $6.29 Million |
|
GreenBank Capital Inc
PINK:GRNBF
|
USA | $6.53 Million |
|
BIOSTIME INTL
BE:8BI
|
Germany | €13.75 Billion |
Liability Composition Analysis (2006–2022)
This chart breaks down Advanced Biomedical Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 22.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Advanced Biomedical Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Advanced Biomedical Technologies Inc (2006–2022)
The table below shows the annual total liabilities of Advanced Biomedical Technologies Inc from 2006 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-10-31 | $8.33 Million | -5.67% |
| 2021-10-31 | $8.83 Million | +12.22% |
| 2020-10-31 | $7.87 Million | +17.54% |
| 2019-10-31 | $6.70 Million | +16.23% |
| 2018-10-31 | $5.76 Million | +13.40% |
| 2017-10-31 | $5.08 Million | +13.84% |
| 2016-10-31 | $4.46 Million | -3.55% |
| 2015-10-31 | $4.63 Million | +16.97% |
| 2014-10-31 | $3.96 Million | +26.33% |
| 2013-10-31 | $3.13 Million | +28.33% |
| 2012-10-31 | $2.44 Million | +37.38% |
| 2011-10-31 | $1.78 Million | +11.63% |
| 2010-10-31 | $1.59 Million | +16.66% |
| 2009-10-31 | $1.36 Million | +48.54% |
| 2008-10-31 | $918.20K | +40136.81% |
| 2007-10-31 | $2.28K | -82.69% |
| 2006-10-31 | $13.18K | -- |